Posterior cingulate γ-aminobutyric acid and glutamate/glutamine are reduced in amnestic mild cognitive impairment and are unrelated to amyloid deposition and apolipoprotein E genotype

Florian Riese, Anton Gietl, Niklaus Zölch, Anke Henning, Ruth O'Gorman, Andrea M. Kälin, Sandra E. Leh, Alfred Buck, Geoffrey Warnock, Richard A.E. Edden, Roger Luechinger, Christoph Hock, Spyros Kollias, Lars Michels

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

The biomarker potential of the inhibitory neurotransmitter γ-aminobutyric acid (GABA) for the invivo characterization of preclinical stages in Alzheimer's disease has not yet been explored. We measured GABA, glutamate+ glutamine (Glx), and N-acetyl-aspartate (NAA) levels by single-voxel MEGA-PRESS magnetic resonance spectroscopy in the posterior cingulate cortex of 21 elderly subjects and 15 patients with amnestic mild cognitive impairment. Participants underwent Pittsburgh Compound B positron emission tomography, apolipoprotein E (APOE) genotyping, and neuropsychological examination. GABA, Glx, and NAA levels were significantly lower in patients. NAA was lower in Pittsburgh Compound B-positive subjects and APOE ε4 allele carriers. GABA, Glx, and NAA levels were positively correlated to CERAD word learning scores. Reductions in GABA, Glx, and NAA levels may serve as metabolic biomarkers for cognitive impairment in amnestic mild cognitive impairment. Because GABA and Glx do not seem to reflect amyloid β deposition or APOE genotype, they are less likely biomarker candidates for preclinical Alzheimer's disease.

Original languageEnglish (US)
Pages (from-to)53-59
Number of pages7
JournalNeurobiology of Aging
Volume36
Issue number1
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint

Aminobutyrates
Gyrus Cinguli
Apolipoproteins E
Glutamine
Amyloid
gamma-Aminobutyric Acid
Glutamic Acid
Genotype
Biomarkers
Alzheimer Disease
Apolipoprotein E4
Positron-Emission Tomography
Neurotransmitter Agents
Cognitive Dysfunction
Magnetic Resonance Spectroscopy
Alleles
N-acetylaspartate
Learning

Keywords

  • Alzheimer
  • APOE
  • Beta-amyloid
  • Dementia
  • GABA
  • Glutamate
  • Glx
  • Magnetic resonance spectroscopy
  • Mild cognitive impairment
  • MRS
  • PiB
  • Posterior cingulate cortex

ASJC Scopus subject areas

  • Neuroscience(all)
  • Aging
  • Clinical Neurology
  • Developmental Biology
  • Geriatrics and Gerontology

Cite this

Posterior cingulate γ-aminobutyric acid and glutamate/glutamine are reduced in amnestic mild cognitive impairment and are unrelated to amyloid deposition and apolipoprotein E genotype. / Riese, Florian; Gietl, Anton; Zölch, Niklaus; Henning, Anke; O'Gorman, Ruth; Kälin, Andrea M.; Leh, Sandra E.; Buck, Alfred; Warnock, Geoffrey; Edden, Richard A.E.; Luechinger, Roger; Hock, Christoph; Kollias, Spyros; Michels, Lars.

In: Neurobiology of Aging, Vol. 36, No. 1, 01.01.2015, p. 53-59.

Research output: Contribution to journalArticle

Riese, F, Gietl, A, Zölch, N, Henning, A, O'Gorman, R, Kälin, AM, Leh, SE, Buck, A, Warnock, G, Edden, RAE, Luechinger, R, Hock, C, Kollias, S & Michels, L 2015, 'Posterior cingulate γ-aminobutyric acid and glutamate/glutamine are reduced in amnestic mild cognitive impairment and are unrelated to amyloid deposition and apolipoprotein E genotype', Neurobiology of Aging, vol. 36, no. 1, pp. 53-59. https://doi.org/10.1016/j.neurobiolaging.2014.07.030
Riese, Florian ; Gietl, Anton ; Zölch, Niklaus ; Henning, Anke ; O'Gorman, Ruth ; Kälin, Andrea M. ; Leh, Sandra E. ; Buck, Alfred ; Warnock, Geoffrey ; Edden, Richard A.E. ; Luechinger, Roger ; Hock, Christoph ; Kollias, Spyros ; Michels, Lars. / Posterior cingulate γ-aminobutyric acid and glutamate/glutamine are reduced in amnestic mild cognitive impairment and are unrelated to amyloid deposition and apolipoprotein E genotype. In: Neurobiology of Aging. 2015 ; Vol. 36, No. 1. pp. 53-59.
@article{e8901520a7cd437c97b9b99d7d219070,
title = "Posterior cingulate γ-aminobutyric acid and glutamate/glutamine are reduced in amnestic mild cognitive impairment and are unrelated to amyloid deposition and apolipoprotein E genotype",
abstract = "The biomarker potential of the inhibitory neurotransmitter γ-aminobutyric acid (GABA) for the invivo characterization of preclinical stages in Alzheimer's disease has not yet been explored. We measured GABA, glutamate+ glutamine (Glx), and N-acetyl-aspartate (NAA) levels by single-voxel MEGA-PRESS magnetic resonance spectroscopy in the posterior cingulate cortex of 21 elderly subjects and 15 patients with amnestic mild cognitive impairment. Participants underwent Pittsburgh Compound B positron emission tomography, apolipoprotein E (APOE) genotyping, and neuropsychological examination. GABA, Glx, and NAA levels were significantly lower in patients. NAA was lower in Pittsburgh Compound B-positive subjects and APOE ε4 allele carriers. GABA, Glx, and NAA levels were positively correlated to CERAD word learning scores. Reductions in GABA, Glx, and NAA levels may serve as metabolic biomarkers for cognitive impairment in amnestic mild cognitive impairment. Because GABA and Glx do not seem to reflect amyloid β deposition or APOE genotype, they are less likely biomarker candidates for preclinical Alzheimer's disease.",
keywords = "Alzheimer, APOE, Beta-amyloid, Dementia, GABA, Glutamate, Glx, Magnetic resonance spectroscopy, Mild cognitive impairment, MRS, PiB, Posterior cingulate cortex",
author = "Florian Riese and Anton Gietl and Niklaus Z{\"o}lch and Anke Henning and Ruth O'Gorman and K{\"a}lin, {Andrea M.} and Leh, {Sandra E.} and Alfred Buck and Geoffrey Warnock and Edden, {Richard A.E.} and Roger Luechinger and Christoph Hock and Spyros Kollias and Lars Michels",
year = "2015",
month = "1",
day = "1",
doi = "10.1016/j.neurobiolaging.2014.07.030",
language = "English (US)",
volume = "36",
pages = "53--59",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Posterior cingulate γ-aminobutyric acid and glutamate/glutamine are reduced in amnestic mild cognitive impairment and are unrelated to amyloid deposition and apolipoprotein E genotype

AU - Riese, Florian

AU - Gietl, Anton

AU - Zölch, Niklaus

AU - Henning, Anke

AU - O'Gorman, Ruth

AU - Kälin, Andrea M.

AU - Leh, Sandra E.

AU - Buck, Alfred

AU - Warnock, Geoffrey

AU - Edden, Richard A.E.

AU - Luechinger, Roger

AU - Hock, Christoph

AU - Kollias, Spyros

AU - Michels, Lars

PY - 2015/1/1

Y1 - 2015/1/1

N2 - The biomarker potential of the inhibitory neurotransmitter γ-aminobutyric acid (GABA) for the invivo characterization of preclinical stages in Alzheimer's disease has not yet been explored. We measured GABA, glutamate+ glutamine (Glx), and N-acetyl-aspartate (NAA) levels by single-voxel MEGA-PRESS magnetic resonance spectroscopy in the posterior cingulate cortex of 21 elderly subjects and 15 patients with amnestic mild cognitive impairment. Participants underwent Pittsburgh Compound B positron emission tomography, apolipoprotein E (APOE) genotyping, and neuropsychological examination. GABA, Glx, and NAA levels were significantly lower in patients. NAA was lower in Pittsburgh Compound B-positive subjects and APOE ε4 allele carriers. GABA, Glx, and NAA levels were positively correlated to CERAD word learning scores. Reductions in GABA, Glx, and NAA levels may serve as metabolic biomarkers for cognitive impairment in amnestic mild cognitive impairment. Because GABA and Glx do not seem to reflect amyloid β deposition or APOE genotype, they are less likely biomarker candidates for preclinical Alzheimer's disease.

AB - The biomarker potential of the inhibitory neurotransmitter γ-aminobutyric acid (GABA) for the invivo characterization of preclinical stages in Alzheimer's disease has not yet been explored. We measured GABA, glutamate+ glutamine (Glx), and N-acetyl-aspartate (NAA) levels by single-voxel MEGA-PRESS magnetic resonance spectroscopy in the posterior cingulate cortex of 21 elderly subjects and 15 patients with amnestic mild cognitive impairment. Participants underwent Pittsburgh Compound B positron emission tomography, apolipoprotein E (APOE) genotyping, and neuropsychological examination. GABA, Glx, and NAA levels were significantly lower in patients. NAA was lower in Pittsburgh Compound B-positive subjects and APOE ε4 allele carriers. GABA, Glx, and NAA levels were positively correlated to CERAD word learning scores. Reductions in GABA, Glx, and NAA levels may serve as metabolic biomarkers for cognitive impairment in amnestic mild cognitive impairment. Because GABA and Glx do not seem to reflect amyloid β deposition or APOE genotype, they are less likely biomarker candidates for preclinical Alzheimer's disease.

KW - Alzheimer

KW - APOE

KW - Beta-amyloid

KW - Dementia

KW - GABA

KW - Glutamate

KW - Glx

KW - Magnetic resonance spectroscopy

KW - Mild cognitive impairment

KW - MRS

KW - PiB

KW - Posterior cingulate cortex

UR - http://www.scopus.com/inward/record.url?scp=84920403220&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920403220&partnerID=8YFLogxK

U2 - 10.1016/j.neurobiolaging.2014.07.030

DO - 10.1016/j.neurobiolaging.2014.07.030

M3 - Article

C2 - 25169676

AN - SCOPUS:84920403220

VL - 36

SP - 53

EP - 59

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

IS - 1

ER -